Journey Medical Q1 2024 Adj EPS $(0.53) Misses $(0.23) Estimate, Sales $13.000M Miss $14.098M Estimate
Benzinga Newsdesk 2 years ago
EarningsEarnings MissesNews
Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.23) by 130.43 percent. The company reported quarterly sales of $13.000 million which missed
Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.23) by 130.43 percent. The company reported quarterly sales of $13.000 million which missed the analyst consensus estimate of $14.098 million by 7.79 percent. This is a 6.44 percent increase over sales of $12.213 million the same period last year.